The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity.
Open accessAbstract
Clonal expansion of CD4+ T cells is a characteristic finding in patients with RA and is only infrequently found in patients with psoriatic arthritis and healthy controls. Expanded CD4+ clonotypes are present in the blood, infiltrate into the joint, and persist over years. We have not addressed the question of whether the expanded clonotypes have unique functional and phenotypic properties which may explain the preferential in vivo expansion in RA. In contrast to most CD4+ T cells, expanded clonotypes lacked the expression of the CD28 and CD7 cell surface molecules. Accordingly, the subsets of CD4+ CD28- (9.7 vs 1.7, P = 0.00002) and CD4+ CD7- T cells (21.5 vs 12.26, P = 0.018) were increased in RA patients compared with age-matched normal individuals. Despite the lack of CD28 expression, clonally expanded CD4+ T cells were not anergic but proliferated in response to immobilized anti-CD3 and could be maintained in tissue culture. In vivo expanded CD4+ T cells were autoreactive to ubiquitously distributed autoantigens. They responded in an autologous mixed lymphocyte reaction, and T cell clones isolated from selected patients proliferated to autologous peripheral blood adherent cells. These data suggest that in RA patients selected CD4+ T cells which share the CD7- CD28- phenotype escape from peripheral tolerance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
Watanabe‐Fukunaga, R., Brannan, C., Copeland, N., Jenkins, N., & Nagata, S. (1992) · Nature · doi:10.1038/356314a0 · Cited by 3,153
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
Dhein, J., Walczak, H., Bäumler, C., Debatin, K., & Krammer, P. (1995) · Nature · doi:10.1038/373438a0 · Cited by 1,814
Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
Ju, S., Panka, D., Cui, H., Ettinger, R., EI-Khatib, M., Sherr, D., Stanger, B., & Marshak-Rothstein, A. (1995) · Nature · doi:10.1038/373444a0 · Cited by 1,709
Epstein, F. H., & Harris, E. D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221805 · Cited by 1,549
Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F., et al. (1995) · Nature · doi:10.1038/373441a0 · Cited by 1,314
The Role of the CD28 Receptor During T Cell Responses to Antigen
Linsley, P. S., & Ledbetter, J. A. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001203 · Cited by 1,298
Moskophidis, D., Lechner, F., Pircher, H., & Zinkernagel, R. M. (1993) · Nature · doi:10.1038/362758a0 · Cited by 1,240
CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
Boise, L., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., & Thompson, C. B. (1995) · Immunity · doi:10.1016/1074-7613(95)90161-2 · Cited by 1,219
Apoptosis And Programmed Cell Death In Immunity
Cohen, J., Duke, R. C., Fadok, V. A., & Sellins, K. S. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.001411 · Cited by 1,112
Lantz, O. J., & Bendelac, A. S. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.3.1097 · Cited by 1,036
Flagged first, then by citations
1 of the 43 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 482
Rheumatoid Arthritis: A Role for Immunosenescence?
Lindström, T. M., & Robinson, W. H. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02965.x · Cited by 124
Telomeres and immunological diseases of aging.
Andrews, N. P., Fujii, H., Goronzy, J. J., & Weyand, C. M. (2010) · Gerontology · doi:10.1159/000268620 · Cited by 108
Self-citationDefective expression of p56lck in an infant with severe combined immunodeficiency.
Goldman, F. D., Ballas, Z. K., Schutte, B. C., Kemp, J. D., Hollenback, C., Noraz, N., & Taylor, N. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3205 · Cited by 120
New insights into the pathogenesis of rheumatoid arthritis
Weyand, C. M. (2000) · Lara D. Veeken · doi:10.1093/oxfordjournals.rheumatology.a031491 · Cited by 119
Self-citationA Transendocytosis Model of CTLA-4 Function Predicts Its Suppressive Behavior on Regulatory T Cells
Hou, T. Z., Qureshi, O., Wang, C. J., Baker, J., Young, S. P., Walker, L. S. K., & Sansom, D. M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401876 · Cited by 123
Central Role of Thrombospondin-1 in the Activation and Clonal Expansion of Inflammatory T Cells
Vallejo, A. N., Muegge, L. O., Klimiuk, P. A., Weyand, C. M., & Goronzy, J. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.2947 · Cited by 116
Self-citationMAGRO, C. M. J., CROWSON, A. N., Kovatich, A. J., & Burns, F. (2003) · Human Pathology · doi:10.1053/hupa.2003.4 · Cited by 118
Rheumatoid Arthritis, Immunosenescence and the Hallmarks of Aging
Chalan, P., van den Berg, A., Kroesen, B., Brouwer, L., & Boots, A. M. H. (2015) · Current Aging Science · doi:10.2174/1874609808666150727110744 · Cited by 117
Rejuvenating the immune system in rheumatoid arthritis.
Weyand, C. M., Fujii, H., Shao, L., & Goronzy, J. J. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.180 · Cited by 112
Self-citationClonally expanded cytotoxic CD4 + T cells and the pathogenesis of IgG4-related disease
Mattoo, H., Stone, J. H., & Pillai, S. S. (2017) · Autoimmunity · doi:10.1080/08916934.2017.1280029 · Cited by 113
The life (and death) of CD 4 + CD 28 null T cells in inflammatory diseases
Dumitriu, I. E. (2015) · Immunology · doi:10.1111/imm.12506 · Cited by 112
Colmegna, I., Diaz‐Borjon, A., Fujii, H., Schaefer, L., Goronzy, J. J., & Weyand, C. M. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23287 · Cited by 108
Self-citationPawelec, G., Adibzadeh, M., Solana, R., & Beckman, I. (1997) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(96)01812-x · Cited by 109
Broadley, I., Pera, A., Morrow, G., Davies, K. A., & Kern, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00195 · Cited by 103
CD4+ and CD8+ cytotoxic T lymphocytes may induce mesenchymal cell apoptosis in IgG4-related disease
Perugino, C. A., Kaneko, N., Maehara, T., Mattoo, H., Kers, J., Allard‐Chamard, H., Mahajan, V. S., Liu, H., Della‐Torre, E., Murphy, S. J. H., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.022 · Cited by 104
Formation of the Killer Ig-Like Receptor Repertoire on CD4+CD28null T Cells
Snyder, M. R., Muegge, L., Offord, C. P., O’Fallon, W. M., Bajzer, Ž., Weyand, C. M., & Goronzy, J. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.3839 · Cited by 104
Self-citationIn Vivo Expression Pattern of MICA and MICB and Its Relevance to Auto-Immunity and Cancer
Schrambach, S., Ardizzone, M., Leymarie, V., Sibilia, J., & Bahram, S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000518 · Cited by 118
Duftner, C., Goldberger, C., Falkenbach, A., Würzner, R., Falkensammer, B., Pfeiffer, K. P., Märker‐Hermann, E., & Schirmer, M. (2003) · Arthritis Research & Therapy · doi:10.1186/ar793 · Cited by 103
Immune aging – A mechanism in autoimmune disease
Zheng, Y., Liu, Q., Goronzy, J. J., & Weyand, C. M. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101814 · Cited by 109
Self-citationBerner, B. R., Wolf, G., Hummel, K. M., Muller, G. A., & Reuss-Borst, M. A. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.3.190 · Cited by 102
Co‐stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28− T cells
Park, W., Weyand, C. M., Schmidt, D., & Goronzy, J. J. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270507 · Cited by 102
Self-citationProduction of Cytokines and Metalloproteinases in Rheumatoid Synovitis Is T Cell Dependent
Klimiuk, P. A., Yang, H., Goronzy, J. J., & Weyand, C. M. (1999) · Clinical Immunology · doi:10.1006/clim.1998.4618 · Cited by 101
Self-citationImmunosenescence in multiple sclerosis: the identification of new therapeutic targets
Dema, M. G., Eixarch, H., Villar, L. M., Montalbán, X., & Espejo, C. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102893 · Cited by 103
Immune Aging and Rheumatoid Arthritis
Goronzy, J. J., Shao, L., & Weyand, C. M. (2010) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2010.03.001 · Cited by 100
Self-citationThe immune system in aging: roles of cytokines, T cells and NK cells
Huang, H. W. (2005) · Frontiers in bioscience · doi:10.2741/1521 · Cited by 98
Wahlstrom, J., Berlin, M., Sköld, C. M., Wigzell, H., Eklúnd, A., & Grünewald, J. (1999) · Thorax · doi:10.1136/thx.54.4.339 · Cited by 98
Cytotoxic CD4+ T Cells Drive Multiple Sclerosis Progression
Peeters, L. M., Vanheusden, M., Somers, V. A., Wijmeersch, B. V., Stinissen, P., Broux, B., & Hellings, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01160 · Cited by 97
Cutaneous T-Cell Lymphoid Dyscrasia
Guitart, J., & MAGRO, C. M. J. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.7.921 · Cited by 95
Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4
Campisi, L., Chizari, S., Ho, J., Gromova, A., Arnold, F. J., Mosca, L., Mei, X., Fstkchyan, Y. S., Torre, D., Beharry, C., et al. (2022) · Nature · doi:10.1038/s41586-022-04844-5 · Cited by 91
Age-associated changes within CD4+ T cells
Kovaiou, R. D., & Grubeck-Loebenstein, B. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.07.006 · Cited by 90
CD7 Is a Differentiation Marker That Identifies Multiple CD8 T Cell Effector Subsets
Aandahl, E. M., Sandberg, J. K., Beckerman, K., Taskén, K., Moretto, W. J., & Nixon, D. F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2349 · Cited by 87
T cell costimulation by fractalkine‐expressing synoviocytes in rheumatoid arthritis
Sawai, H., Park, Y. W., Roberson, J., Imai, T., Goronzy, J. J., & Weyand, C. M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21140 · Cited by 86
Self-citationParish, S. T., Wu, J. E., & Effros, R. B. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9449-7 · Cited by 85
Modulation of T Lymphocyte Replicative Senescence via TNF-α Inhibition: Role of Caspase-3
Parish, S. T., Wu, J. E., & Effros, R. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803449 · Cited by 86
Kobayashi, T., Okamoto, S., Iwakami, Y., Nakazawa, A., Hisamatsu, T., Chinen, H., Kamada, N., Imai, T., Goto, H., & Hibi∥, T. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20113 · Cited by 87
High Prevalence of Circulating CD4+CD28−T-Cells in Patients With Small Abdominal Aortic Aneurysms
Duftner, C., Seiler, R., Klein-Weigel, P. F., Göbel, H., Goldberger, C., Ihling, C. H., Fraedrich, G., & Schirmer, M. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000167520.41436.c0 · Cited by 85
Bone and Cytokines: Beyond IL-1, IL-6 and TNF-α
Rifas, A. (1999) · Calcified Tissue International · doi:10.1007/s002239900570 · Cited by 84
Quandt, D., Rothe, K., Scholz, R., Baerwald, C., & Wagner, U. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093293 · Cited by 86
Dessein, P. H., Joffe, B. I., Stanwix, A. E., Botha, A. S., & Moomal, Z. (2002) · PubMed · Cited by 83
Dietary n-3 polyunsaturated fatty acids modulate purified murine T-cell subset activation
Arrington, J. L., Chapkin, R. S., Switzer, K. C., Morris, J. S., & McMurray, D. N. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01627.x · Cited by 83
T-Cell Immunity in Acute Coronary Syndromes
Weyand, C. M., Goronzy, J. J., Liuzzo, G., Kopecky, S. L., Holmes, D. R., & Frye, R. L. (2001) · Mayo Clinic Proceedings · doi:10.4065/76.10.1011 · Cited by 81
Self-citationShi, B., Du, X., Wang, Q., Chen, Y., & Zhang, X. (2013) · Metabolism · doi:10.1016/j.metabol.2012.12.005 · Cited by 81
Activating NK‐cell receptors co‐stimulate CD4+CD28− T cells in patients with rheumatoid arthritis
Fasth, A. E. R., Björkström, N. K., Anthoni, M., Malmberg, K., & Malmström, V. (2009) · European Journal of Immunology · doi:10.1002/eji.200939399 · Cited by 79
Costimulatory mechanisms in the elderly
Effros, R. B. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00503-4 · Cited by 79
ERK-Dependent T Cell Receptor Threshold Calibration in Rheumatoid Arthritis
Singh, K., Deshpande, P., Pryshchep, S., Colmegna, I., Liarski, V. M., Weyand, C. M., & Goronzy, J. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901784 · Cited by 79
Self-citationSnyder, M. R., Nakajima, T. E., Leibson, P. J., Weyand, C. M., & Goronzy, J. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3725 · Cited by 78
Self-citationHighly Activated T-Cell Receptor AV2S3+ CD4+ Lung T-Cell Expansions in Pulmonary Sarcoidosis
Katchar, K., WAHLSTRÖM, J., Eklúnd, A., & Grünewald, J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.2005028 · Cited by 78
Weyand, C. M., & Goronzy, J. J. (2000) · Arthritis Research · doi:10.1186/ar90 · Cited by 78
Self-citationT cell immunosenescence in vitro and in vivo
Pawelec, G., Wagner, W., Adibzadeh, M., & Engel, A. (1999) · Experimental Gerontology · doi:10.1016/s0531-5565(99)00002-9 · Cited by 78
Yang, Z., Kim, H. J., Villasboas, J. C., Price-Troska, T. L., Jalali, S., Wu, H., Luchtel, R. A., Polley, M. C., Novak, A. J., & Ansell, S. M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.085 · Cited by 77
IL-15 Amplifies the Pathogenic Properties of CD4+CD28− T Cells in Multiple Sclerosis
Broux, B., Mizee, M. R., Vanheusden, M., van der Pol, S. M. A., van Horssen, J., Wijmeersch, B. V., Somers, V. A., de Vries, H. E., Stinissen, P., & Hellings, N. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401547 · Cited by 76
DNA damage, metabolism and aging in pro-inflammatory T cells
Li, Y., Goronzy, J. J., & Weyand, C. M. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.10.027 · Cited by 80
Self-citationScarsi, M., ZIGLIOLI, T., & Airó, P. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.091176 · Cited by 76
NKG2D expression in CD4+ T lymphocytes as a marker of senescence in the aged immune system
Alonso‐Arias, R., Moro‐García, M. A., López‐Vázquez, A., Rodrigo, L., Baltar, J., García, F. M. S., Jaurrieta, J. J. S., & López‐Larrea, C. (2011) · AGE · doi:10.1007/s11357-010-9200-6 · Cited by 76
Vallejo, A. N., Yang, H., Klimiuk, P. A., Weyand, C. M., & Goronzy, J. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1732 · Cited by 75
Self-citationThe Story of CD4+CD28−T Cells Revisited: Solved or Still Ongoing?
Maly, K., & Schirmer, M. (2015) · Journal of Immunology Research · doi:10.1155/2015/348746 · Cited by 77
Premature aging of the immune system in children with juvenile idiopathic arthritis
Prelog, M., Schwarzenbrunner, N., Sailer‐Höck, M., Kern, H., Klein‐Franke, A., Ausserlechner, M. J., Koppelstaetter, C., Brunner, A., Duftner, C., Dejaco, C., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23599 · Cited by 76
Snyder, M. R., Lucas, M., Vivier, É., Weyand, C. M., & Goronzy, J. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20020383 · Cited by 74
Self-citationCytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges
Kyaw, T. S., Peter, K., Li, Y., Tipping, P. G., Toh, B., & Bobik, A. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13845 · Cited by 73
Fasth, A. E. R., Cao, D., Van Vollenhoven, R., Trollmo, C., & Malmström, V. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01464.x · Cited by 73
CD8+CD28– T cells: Certainties and uncertainties of a prevalent human T‐cell subset
Arosa, F. A. (2002) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2002.01057.x · Cited by 73
Costimulation of human CD28– T cells by 4‐1BB ligand
Bukczynski, J., Wen, T., & Watts, T. H. (2003) · European Journal of Immunology · doi:10.1002/immu.200310020 · Cited by 72
Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies
Watanabe, N., Mo, F., Zheng, R., Ma, R., Bray, V. C., van Leeuwen, D. G., Sritabal-Ramirez, J., Hu, H., Wang, S., Mehta, B., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.09.003 · Cited by 75
Yamada, H., Nakashima, Y., Okazaki, K., Mawatari, T., Fukushi, J., Oyamada, A., Fujimura, K., Iwamoto, Y., & Yoshikai, Y. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.101355 · Cited by 72
Yokoyama, Y., Fukunaga, K., Fukuda, Y., Tozawa, K., Kamikozuru, K., Ohnishi, K., Kusaka, T., Kosaka, T., Hida, N., Ohda, Y., et al. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9560-z · Cited by 72
Disease modification and cardiovascular risk reduction: two sides of the same coin?
Hall, F. C., & Dalbeth, N. (2005) · Rheumatology · doi:10.1093/rheumatology/kei012 · Cited by 71
Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults
Turner, J. E., Campbell, J. P., Edwards, K. M., Howarth, L. J., Pawelec, G., Aldred, S., Moss, P., Drayson, M. T., Burns, V. E., & Bosch, J. A. (2014) · AGE · doi:10.1007/s11357-013-9557-4 · Cited by 87
DNA-dependent protein kinase catalytic subunit mediates T-cell loss in rheumatoid arthritis.
Shao, L., Goronzy, J. J., & Weyand, C. M. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000096 · Cited by 69
Self-citationTaneja, V., & David, C. S. (2009) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00858.x · Cited by 69
CD56‐expressing T cells that have features of senescence are expanded in rheumatoid arthritis
Michel, J. J., Turesson, C., Lemster, B. H., Atkins, S. R., Iclozan, C., Bongartz, T., Wasko, M. C., Matteson, E. L., & Vallejo, A. N. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22310 · Cited by 69
Wedderburn, L. R., Patel, A., Varsani, H., & Woo, P. M. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01194.x · Cited by 68
Tran, C. N., Thacker, S. G., Louie, D. M., Oliver, J. A., White, P. T., Endres, J., Urquhart, A. G., Chung, K. C., & Fox, D. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.2989 · Cited by 66
Engineering naturally occurring CD7− T cells for the immunotherapy of hematological malignancies
Freiwan, A., Zoine, J. T., Crawford, J. C., Vaidya, A. B., Schattgen, S., Myers, J., Patil, S. L., Khanlari, M., Inaba, H., Klco, J. M., et al. (2022) · Blood · doi:10.1182/blood.2021015020 · Cited by 66
Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases
Yasumizu, Y., Takeuchi, D., Morimoto, R., Takeshima, Y., Okuno, T., Kinoshita, M., Morita, T., Kato, Y., Wang, M., Motooka, D., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2023.100473 · Cited by 60
Association of Graves’ Disease and Prevalence of Circulating IFN-γ-producing CD28− T Cells
Sun, Z., Zhong, W., Lü, X., Shi, B., Zhu, Y., Chen, L., Zhang, G., & Zhang, X. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9213-4 · Cited by 64
Scarsi, M., ZIGLIOLI, T., & Airò, P. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.110386 · Cited by 64
Hebbar, M., Jeannin, P., Magistrelli, G., Hatron, P.-Y., HACHULLA, E., Devulder, B., BONNEFOY, J.-Y., & Delneste, Y. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02427.x · Cited by 63
WINCHESTER, R. J., Wiesendanger, M., O’Brien, W., Zhang, H.-Z., Maurer, M. S., Gillam, L. D., Schwartz, A. J., Marboe, C. C., & Stewart, A. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003521 · Cited by 63
Pierer, M., Rothe, K., Quandt, D., Schulz, A., Rossol, M., Scholz, R., Baerwald, C., & Wagner, U. G. (2011) · Arthritis & Rheumatism · doi:10.1002/art.34346 · Cited by 66
Senescent profile of angiogenic T cells from systemic lupus erythematosus patients
López, P., Rodríguez‐Carrio, J., Martínez-Zapico, A., Caminal‐Montero, L., & Suárez, A. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.5hi0215-042r · Cited by 62
Wagner, U. G., Pierer, M., Kaltenhäuser, S., Wilke, B., Seidel, W., Arnold, S., & Häntzschel, H. (2002) · European Journal of Immunology · doi:10.1002/immu.200390010 · Cited by 61
Colombatti, A., Doliana, R., Schiappacassi, M., Argentini, C., Tonutti, E., Feruglio, C., & Sala, P. (1998) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1998.4580 · Cited by 61
CD4+CD7− T Cells: A Separate Subpopulation of Memory T Cells?
Reinhold, U., & Abken, H. (1997) · Journal of Clinical Immunology · doi:10.1023/a:1027318530127 · Cited by 60
T-cell responses in rheumatoid arthritis
Weyand, C. M., & Goronzy, J. J. (1999) · Current Opinion in Rheumatology · doi:10.1097/00002281-199905000-00010 · Cited by 60
Self-citationAltered T-cell subtypes in spondyloarthritis, rheumatoid arthritis and polymyalgia rheumatica
Dejaco, C., Duftner, C., Klauser, A. S., & Schirmer, M. (2009) · Rheumatology International · doi:10.1007/s00296-009-0949-9 · Cited by 59
Rizzello, V., Liuzzo, G., Brugaletta, S., Rebuzzi, A. G., Biasucci, L. M., & Crea, F. (2006) · Circulation · doi:10.1161/circulationaha.105.588533 · Cited by 58
Brugaletta, S., Biasucci, L. M., Pinnelli, M., Biondi‐Zoccai, G., Giannuario, G. D., Trotta, G., Liuzzo, G., & Crea, F. (2006) · Heart · doi:10.1136/hrt.2004.052282 · Cited by 58
Fractalkine mediates T cell–dependent proliferation of synovial fibroblasts in rheumatoid arthritis
Sawai, H., Park, Y. W., He, X., Goronzy, J. J., & Weyand, C. M. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22919 · Cited by 59
Self-citationFiehn, C. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh254 · Cited by 58
Amyes, E., McMichael, A. J., & Callan, M. F. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5765 · Cited by 65
Melis, L., Praet, L. V., Pircher, H., Venken, K., & Elewaut, D. S. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203881 · Cited by 57
T Cell Receptor Repertoire in Rheumatoid Arthritis
Goronzy, J. J., Zettl, A., & Weyand, C. M. (1998) · International Reviews of Immunology · doi:10.3109/08830189809054410 · Cited by 57
Self-citationHur, Y., Suh, C., Kim, S., & Won, J. (2006) · Journal of Clinical Immunology · doi:10.1007/s10875-006-9057-8 · Cited by 59
Fontenot, A. P., Gharavi, L., Bennett, S. R., Canavera, S. J., Newman, L. S., & Kotzin, B. L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18317 · Cited by 57
The molecular basis of rheumatoid arthritis
Weyand, C. M., & Goronzy, J. J. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050167 · Cited by 57
Self-citationTissue trafficking patterns of effector memory CD4 T cells in rheumatoid arthritis.
Zhang, X., Nakajima, T., Goronzy, J. J., & Weyand, C. M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21482 · Cited by 56
Self-citationXu, J., Vallejo, A. N., Jiang, Y.-F., Weyand, C. M., & Goronzy, J. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500727200 · Cited by 56
Self-citationRückert, R., Brandt, K., Ernst, M., Marienfeld, K., Csernok, E., Metzler, C., Budagian, V., Bulanova, E., Paus, R., & Bulfone‐Paus, S. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02878.x · Cited by 56
Blaschke, S., Middel, P., Dorner, B. G., Blaschke, V., Hummel, K. M., Kroczek, R. A., Reich, K., Benöhr, P., Koziolek, M. J., & Muller, G. A. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11171 · Cited by 56
Regulatory T cells: Possible mediators for the anti-inflammatory action of statins
Shahbaz, S. K., Sadeghi, M., Koushki, K., Penson, P. E., & Sahebkar, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104469 · Cited by 58
Metadata
- Authors
- Schmidt, D., Goronzy, J. J., & Weyand, C. M.
- Affiliations
- Mayo Clinic (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1996-05-01
- Volume
- 97
- Issue
- 9
- Pages
- 2027-2037
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC507276
- OpenAlex
- W1982865105
- Cited by
- 482
- References
- 43
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 10 · 2023: 5 · 2022: 13 · 2021: 15 · 2020: 12 · 2019: 15 · 2018: 10 · 2017: 18 · 2016: 7 · 2015: 20 · 2014: 12 · 2013: 23 · 2012: 11
- FWCI
- 18.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Arthritis Foundation
- Mayo Foundation for Medical Education and Research
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR041974, R01 AR 41974, R01AR042527, R01AR42527)
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- rheumatoid arthritis, CD4+ T cells, clonal expansion, CD28, CD7, autoreactivity, peripheral tolerance, T cell anergy, autoantigens, mixed lymphocyte reaction, T cell proliferation, psoriatic arthritis
- MeSH terms
- Arthritis, Rheumatoid, Autoantigens, Base Sequence, Clone Cells, Humans, Lymphocyte Activation, Molecular Sequence Data, CD4-Positive T-Lymphocytes, Immunophenotyping, T-Lymphocyte Subsets, CD28 Antigens, Antigens, CD7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review